Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Axon Enterprise stock target raised on strong Q1 performance

EditorNatashya Angelica
Published 2024-05-07, 11:12 a/m
AXON
-

Tuesday - Axon Enterprise Inc. (NASDAQ:AXON) has seen an increase in its stock price target from $325.00 to $370.00 by Craig-Hallum, while the firm maintains a Buy rating on the stock. The adjustment comes after Axon reported a robust first quarter, surpassing expectations for both revenue and earnings. The quarter was marked by the largest growth in Annual Recurring Revenue (ARR) in the company's history.

The Software & Sensors segment, particularly Axon Body sales, was noted as a significant contributor to the quarter's success. The company is gaining momentum with a newly estimated Total Addressable Market (TAM) of $77 billion. This growth projection follows the introduction of Draft One, an AI-driven report writing software, and the acquisition of Dedrone, a prominent player in the airspace security market.

These strategic moves are expected to propel Axon to new heights, as the firm believes they will support the company's continued ascent. There is also a strong growth potential identified in Axon's legacy product lines, especially the TASER line, which has significant opportunities in international markets that prohibit weapons.

Craig-Hallum highlights the intellectual property associated with the AXON brand and its suite of interconnected products as a key competitive advantage. This "unique moat" is anticipated to support the company's ability to sustain a 20% to 30% annual growth rate in top-line revenue for the foreseeable future. With these factors in mind, the firm reaffirms its Buy rating and raises the price target for Axon Enterprise.

InvestingPro Insights

Following the positive outlook from Craig-Hallum, Axon Enterprise Inc. (NASDAQ:AXON) continues to demonstrate strong financial metrics that may interest investors. With a market capitalization of $24.72 billion and a significant revenue growth of 31.38% in the last twelve months as of Q4 2023, Axon showcases its expanding market presence. The company's gross profit margin stands impressively at 61.11%, reflecting its ability to maintain profitability amidst its growth trajectory.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Two notable InvestingPro Tips for Axon relate to its balance sheet and profitability. First, the company holds more cash than debt, which is a reassuring sign of financial stability. Second, Axon is expected to see net income growth this year, indicating a positive outlook for earnings. These insights suggest that Axon's financial health is robust, supporting the potential for continued appreciation in its stock price.

For investors looking for more detailed analytics and additional InvestingPro Tips, there are 19 more listed on InvestingPro for Axon, which can be accessed by visiting the company's page on the platform. To enhance your investment research, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. This offer could provide valuable insights for those considering an investment in Axon's promising future.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.